FDA Limits On Vasopressin Compounding Valid, Says Judge

A D.C. federal judge on Thursday chucked a challenge to the U.S. Food and Drug Administration's limits on drug compounding with the hormone vasopressin, rejecting assertions that the agency is improperly...

Already a subscriber? Click here to view full article